Skip to content
by Legal Desire
25 May 2026

Latham & Watkins Advises SPR Therapeutics in US$650 Acquisition by Medtronic

Advising firms

Deal team

18 lawyers named
LawyerFirmSeniorityPracticeOffice
Hans Brigham Lead Latham & Watkins LLP Partner corporate Boston
Julie Scallen Lead Latham & Watkins LLP Partner corporate Boston
Jihoo Kim Latham & Watkins LLP Associate corporate Not stated
Andrew Wang Latham & Watkins LLP Associate corporate Not stated
Katharine Moir Latham & Watkins LLP Partner tax Bay Area
Jay Khurana Latham & Watkins LLP Associate tax Not stated
Josh Friedman Latham & Watkins LLP Partner benefits Boston
Rebecca Fishbein Latham & Watkins LLP Associate benefits Not stated
Eliot Choy Latham & Watkins LLP Counsel intellectual property New York
Patrick Chew Latham & Watkins LLP Associate intellectual property Not stated
Heather Deixler Latham & Watkins LLP Partner data privacy and cybersecurity Bay Area
Chad Leiper Latham & Watkins LLP Associate data privacy and cybersecurity Not stated
Chad Jennings Latham & Watkins LLP Counsel FDA Washington, D.C.
Betty Pang Latham & Watkins LLP Partner healthcare regulatory Bay Area
Yanyan Zhou Latham & Watkins LLP Counsel healthcare regulatory Los Angeles
Patrick English Latham & Watkins LLP Partner antitrust Washington, D.C.
Linda Wang Latham & Watkins LLP Associate antitrust Not stated
Harrison White Latham & Watkins LLP Partner insurance Los Angeles

15 more lawyers on this deal. Register free to see the full deal team, with seniority, practice and office.

REGISTER FREE SIGN IN

Want co-counsel patterns, repeat clients and alerts when these firms land their next deal? Get Pro.

Stated terms

Stated value
USD 650m (US$650 million)
What the figure measures
Total transaction value
Client
SPR Therapeutics, Inc.Sell-side
Counterparties
Medtronic plc (Buy-side)